Compare Lowe`s Companies Inc (LOW) vs Novavax Inc (NVAX) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Lowe`s Companies Inc vs Novavax Inc — how do they compare? Lowe`s Companies Inc trades at $203.56 (market cap $114.78B), while Novavax Inc trades at $8.06 (market cap $1.30B). The key difference: Lowe`s Companies Inc is far larger — about 88.3× Novavax Inc's market cap, and Lowe`s Companies Inc pays a 2.44% dividend while Novavax Inc pays none. Which is the better fit depends on your goals.
| LOW | NVAX | |
|---|---|---|
Market Cap | $114.78B | $1.30B |
Sector | Consumer Cyclical | Health |
52-Week High | $287.39 | $11.19 |
52-Week Low | $204.76 | $6.22 |
Enterprise Value | $156.54B | $800.50M |
Dividend Yield | 2.44% | — |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Lowe`s Companies Inc
Lowe's is the second-largest home improvement retailer in the world, operating 1,969 stores and servicing around 230 dealer-owned stores throughout the United States and Canada. The firm's stores offer products and services for home decorating, maintenance, repair, and remodeling, with maintenance and repair accounting for two thirds of products sold. Lowe's targets retail do-it-yourself (around 75% of sales) and do-it-for-me customers as well as commercial and professional business clients (around 25% of sales). We estimate Lowe's captures a low-double-digit share of the domestic home improvement market, based on U.S. Census data and management's estimates for market size.
Read more on LOW →About Novavax Inc
Novavax, Inc. is a clinical stage biotechnology company. The Company creates novel vaccines to address a broad range of infectious diseases worldwide using proprietary virus-like particle (VLP) technology.
Read more on NVAX →
